We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
-13.5%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$3.6M
Cap. Flow
+$23.7M
Cap. Flow %
18.72%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
LMDX
LumiraDx Limited Common Shares
LMDX
+$23.7M

Top Sells

Rank Stock Value
1
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$21.5K

Sector Composition

Rank Sector Weight
1 Healthcare 99.29%
2 Materials 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIR icon
1
Vir Biotechnology
VIR
$1.49B
$30.1M 23.79%
1,559,142
– –
IMCR icon
2
Immunocore
IMCR
$1.78B
$27.1M 21.42%
576,923
– –
BNTX icon
3
BioNTech
BNTX
$22.8B
$20.1M 15.89%
148,674
– –
LMDX
4
DELISTED
LumiraDx Limited Common Shares
LMDX
$14.6M 11.54%
+14,285,714
New +$23.7M
CVAC
5
DELISTED
CureVac
CVAC
$13.5M 10.67%
1,709,781
– –
EXAI
6
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$13.1M 10.36%
1,590,909
– –
BFLY icon
7
Butterfly Network
BFLY
$1.75B
$4.8M 3.79%
1,011,003
– –
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2.1M 1.66%
1,320,880
-10,478
-0.8% -$21.5K
AMRS
9
DELISTED
Amyris Inc.
AMRS
$900K 0.71%
292,398
– –
ZY
10
DELISTED
Zymergen Inc. Common Stock
ZY
$200K 0.16%
59,970
– –

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q3 2022 Portfolio in Review

As of Q3 2022, Gates Foundation held 10 positions worth $127M, down 2.8% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation deployed $23.7M of net new capital in Q3 2022, opening 1 new position. Its largest new stake was LumiraDx Limited Common Shares: 14,285,714 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Materials.

On the sell side, the largest reduction was Atreca, Inc. Class A Common Stock, an estimated $21.5K trimmed.

  • Gates Foundation's largest Q3 2022 buy was LumiraDx Limited Common Shares: 14,285,714 shares worth $14.6M.
  • Gates Foundation's biggest Q3 2022 reduction was Atreca, Inc. Class A Common Stock, cutting an estimated $21.5K.
  • Gates Foundation's ten largest holdings make up 100% of its $127M portfolio in Q3 2022.
  • Gates Foundation opened 1 new position and closed 0 in Q3 2022.
  • Gates Foundation's portfolio value fell 2.8% quarter-over-quarter to $127M.

Based on Gates Foundation's 13F filing for Q3 2022, filed 14 Nov 2022.